Monoclonal antibodies prevent COVID-19 inflammation in macaques
Neutralising monoclonal antibodies protected aged macaque monkeys from SARS-CoV-2 and reduced inflammation, including in cerebrospinal fluid, a new study has shown.
List view / Grid view
Neutralising monoclonal antibodies protected aged macaque monkeys from SARS-CoV-2 and reduced inflammation, including in cerebrospinal fluid, a new study has shown.
In non-human primates, researchers have found that mesenchymal stem cells were effective at strengthening the immune response to HIV.
Scientists have developed a model of the early stages of Alzheimer's disease in rhesus macaques to better test new treatments.
A study has shown that the immune response of rhesus macaques with SARS-CoV-2 could be reproduced with a vaccine.
A non-hallucinogenic version of the psychedelic drug ibogaine could treat psychiatric disorders, pre-clinical trials have shown.
A study has discovered a molecule key in neuronal growth that could be used as a drug target to treat anxiety-related diseases.